Drug repositioning refers to the concept of discovering novel clinical benefits of drugs that
are already known for use treating other diseases. The advantages of this are that several …

Cancer rates are set to increase at an alarming rate, from 10 million new cases globally in
2000 to 15 million in 2020. Regarding the pharmacological treatment of cancer, we currently …

Cancer is a leading cause of death worldwide, and the incidence continues to increase.
Despite major research aimed at discovering and developing novel and effective anticancer …

Highlights•De novo anticancer drug discovery is challenging and repurposing in oncology is
a promising field.•Drug repositioning increasingly emerges as faster, cheaper and …

Drug repositioning (also referred to as drug repurposing), the process of finding new uses of
existing drugs, has been gaining popularity in recent years. The availability of several …

Drug discovery and development is a time consuming, costly and risky venture. As an
alternative approach, pharmaceutical companies have adopted drug repositioning (also …

Drug repositioning is the process of developing new indications for existing drugs or
biologics. Increasing interest in drug repositioning has occurred due to sustained high …

Drug repositioning is a powerful method that can assists the conventional drug discovery
process by using existing drugs for treatment of a disease rather than its original indication …

Drug discovery and development are long and financially taxing processes. On an average
it takes 12–15 years and costs 1.2 billion USD for successful drug discovery and approval …

Highlights•Publications for drug repositioning have drastically increased in past five
years.•Different types of drug repositioning and available resources have been …